Akkurt Arslan, Murat
Brignole-Baudouin, Françoise
Chardonnet, Solenne
Pionneau, Cédric
Blond, Frédéric
Baudouin, Christophe
Kessal, Karima
Funding for this research was provided by:
IHU FOReSIGHT (ANR-18-IAHU-01, ANR-18-IAHU-01, ANR-18-IAHU-01, ANR-18-IAHU-01, ANR-18-IAHU-01, ANR-18-IAHU-01, ANR-18-IAHU-01)
H2020-MSCA-ETN program (765608, 765608, 765608)
Fondation de France (00131209 / WB-2022-43019, 00131209 / WB-2022-43019, 00131209 / WB-2022-43019)
LabEx LIFESENSES (ANR-10-LABX-65, ANR-10-LABX-65, ANR-10-LABX-65, ANR-10-LABX-65, ANR-10-LABX-65, ANR-10-LABX-65)
Article History
Received: 1 February 2023
Accepted: 5 September 2023
First Online: 14 September 2023
Competing interests
: Professor Christophe Baudouin is a consultant for Oculis, Alcon, Allergan, Horus Pharma, Santen, and Théa; Professor Christophe Baudouin and Dr. Françoise Brignole-Baudouin have received research grants from Horus Pharma, Santen, and Théa. Karima Kessal has received research grants from Santen. The other authors have no competing interests.